| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 52.09B | 52.37B | 52.01B | 51.12B | 51.62B | 47.65B |
| Gross Profit | 5.62B | 5.84B | 5.56B | 5.84B | 5.09B | 5.24B |
| EBITDA | 4.71B | 5.41B | 5.23B | 5.28B | 4.49B | 4.67B |
| Net Income | 2.21B | 2.46B | 2.21B | 2.27B | 1.77B | 1.95B |
Balance Sheet | ||||||
| Total Assets | 47.34B | 48.07B | 47.48B | 46.73B | 42.31B | 41.25B |
| Cash, Cash Equivalents and Short-Term Investments | 13.97B | 14.51B | 13.95B | 12.24B | 9.45B | 8.27B |
| Total Debt | 6.64B | 6.34B | 7.00B | 8.15B | 7.14B | 8.11B |
| Total Liabilities | 21.00B | 19.97B | 21.71B | 22.70B | 20.27B | 20.68B |
| Stockholders Equity | 26.34B | 28.09B | 25.77B | 24.02B | 22.03B | 20.55B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 2.86B | 2.70B | -208.00M | 2.03B | 2.62B |
| Operating Cash Flow | 0.00 | 4.30B | 3.80B | 4.58B | 3.58B | 3.80B |
| Investing Cash Flow | 0.00 | -1.45B | -1.13B | -3.14B | -1.25B | -1.94B |
| Financing Cash Flow | 0.00 | -1.20B | -1.76B | 610.00M | -1.40B | -1.30B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | ¥19.70B | 11.05 | ― | 2.46% | 0.69% | 11.33% | |
73 Outperform | ¥382.95B | 17.88 | 5.53% | 4.35% | 10.25% | 36.09% | |
73 Outperform | ¥117.61B | 12.80 | ― | 3.57% | 3.07% | -0.96% | |
64 Neutral | ¥5.69B | 37.38 | ― | 1.62% | 8.05% | 65.93% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
60 Neutral | ¥255.83B | 14.37 | 4.72% | 1.66% | 5.32% | 71.96% | |
50 Neutral | ¥607.36B | -12.02 | 7.44% | 2.10% | 5.84% | -61.24% |